Bastyr University: Clinical Trials

26 trials sponsored by Bastyr University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 2 recruiting, 2 terminated, 1 suspended. 10 Not applicable, 5 Phase 1, 2 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 9, Suspended 1
Phase 15Completed 2, Terminated 2, Withdrawn 1
Phase 22Completed 2
Early Phase 11Completed 1

Follow Bastyr University: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Biofeedback for Psoriasis
HRV-Biofeedback/Mind-Body Therapy - Psoriasis, Psoriasis Vulgaris
Not applicableCompletedBastyr University52022-06-072024-07-09
Environmental Toxicants Avoidance Study
Avoidance Education - Pollution; Exposure, Glucose Intolerance
Not applicableSuspendedBastyr University202022-05-012024-09-27
Biological and Psychological Health Effect of Ramadan Study
Ramadan fasting, praying, and welfare for poor - Quality of Life
UnknownBastyr University152021-04-082021-04-15
Omega 7 Oil and Inflammatory Biomarker Study
omega 7, Placebo - Musculoskeletal Pain
Not applicableCompletedBastyr University562017-09-012019-10-15
Addressing Microaggressions in Racially Charged Patient-provider Interactions: A Pilot Randomized Trial
Bias-reduction Intervention - Racism
Not applicableCompletedUniversity of Washington252016-05-242019-12-03
Phase IIb Study of Intranasal Glutathione in Parkinson's Disease
Reduced Glutathione 100mg, Reduced Glutathione 200mg, Placebo - Parkinson's Disease
Phase 2CompletedBastyr University452015-04-012016-06-24
The Canadian/US Integrative Oncology Study
Breast Neoplasms, Colorectal Neoplasms
CompletedThe Canadian College of Naturopathic Medicine4002015-01-012023-12-14
Cannabis and Parkinson's Disease Tremor: A Natural History Study
Parkinson's Disease
CompletedBastyr University112013-11-012016-06-27
Complementary and Alternative Medicine Sauna Detoxification Study: Phase I
Sauna Detoxification Protocol, Observation Sessions - Hyperthermia
Phase 1TerminatedBastyr University12013-07-012015-04-17
A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer
Docetaxel, PSK®, Docetaxel, Placebo - Prostatic Neoplasms
Phase 1WithdrawnBastyr University2013-05-012015-10-27
Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.
Quercetin, Acarbose, placebo - Diabetes Mellitus, Type 2
Phase 2CompletedBastyr University192013-05-012015-03-18
Haptoglobin and Iron in Parkinson's Disease
Parkinson's Disease
CompletedBastyr University3422013-02-012016-11-29
Evaluation of Coagulation in Multiple Sclerosis
Multiple Sclerosis
CompletedBastyr University692012-10-012017-07-28
Modifiable Variables in Parkinsonism (MVP)
Parkinson's Disease, Parkinsonism
RecruitingBastyr University20002012-09-012022-03-25
Intranasal Glutathione in Parkinson's Disease
Intranasal glutathione - (in)GSH, Saline Intranasal Delivery - Parkinson's Disease (PD)
Phase 1CompletedBastyr University342012-07-012017-07-31
Complementary and Alternative Care in Multiple Sclerosis
Multiple Sclerosis
RecruitingBastyr University10002012-06-012020-02-11
Sauna Detoxification Study: Pilot Feasibility
This protocol will utilize a sauna as the primary method of detoxification. - Hyperthermia
Phase 1CompletedBastyr University102011-11-012012-10-30
Comparative Effectiveness of Vitamin D and Repletion Strategies
Vitamin D3 - Hypovitaminosis D, Insulin Resistance
Not applicableCompletedBastyr University662010-08-012012-02-02
Integrative Oncology Outcomes Study in Breast Cancer
Breast Cancer
CompletedBastyr University7502010-08-012018-03-22
Resveratrol and Midazolam Metabolism
Midazolam, resveratrol (single dose), resveratrol (multiple dose) - Healthy
Not applicableCompletedUniversity of Washington62010-07-012017-10-31

Showing 20 of 26. Sign in to see all of them.

Conditions studied

Parkinson Disease (5)  ·  Diabetes Mellitus, Type 2 (4)  ·  Breast Neoplasms (2)  ·  Hyperthermia (2)  ·  Multiple Sclerosis (2)  ·  Adenocarcinoma (1)  ·  Anxiety Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Corticobasal Degeneration (1)  ·  Depression (1)  ·  Diabetes Mellitus (1)  ·  Glucose Intolerance (1)  ·  Hyperglycemia (1)  ·  Inflammation (1)

Interventions

Acarbose (1)  ·  Acupuncture Therapy (1)  ·  Calcitriol (1)  ·  Cholecalciferol (1)  ·  Docetaxel (1)  ·  Glutathione (1)  ·  Midazolam (1)  ·  Poverty (1)  ·  Quercetin (1)  ·  Resveratrol (1)  ·  Social Work (1)  ·  Sodium Chloride (1)  ·  Tai Ji (1)  ·  omega-aminoenantic acid (1)  ·  phosphoribosylanthranilate isomerase (1)

Countries

United States (26)  ·  Canada (1)

Top investigators

Ryan Bradley, ND, MPH (3)  ·  Laurie K Mischley, ND (2)  ·  Laurie K Mischley, ND, PhD, MPH (2)  ·  Masa Sasagawa, ND, PhD (2)  ·  Paola Costa-Mallen, PhD (2)  ·  Ryan Bradley, ND (2)  ·  Celestia Higano, MD (1)  ·  Cynthia A Wenner, Ph.D (1)  ·  Dugald Seely, ND, MSc (1)  ·  Guan-Cheng Sun, PhD (1)  ·  Jason Allen, N.D., MPH (1)  ·  Jason Allen, ND, MPH (1)  ·  Jennifer C Lovejoy, PhD (1)  ·  Jennifer Lovejoy, PhD (1)  ·  Jonathan Kanter, Ph.D. (1)

Results publications

PMID 12222941, PMID 12771261, PMID 1454205, PMID 16376913, PMID 20040671, PMID 20345926, PMID 2911028, PMID 29701107, PMID 8080242, PMID 8938817, PMID 9444566

NIH funding

R00AT004711 (2), K01AT004404 (1), R01AT005873 (1)